Alternating Diet as a Preventive and Therapeutic Intervention for High Fat Diet-induced Metabolic Disorder

被引:5
作者
Ma, Yongjie [1 ]
Gao, Mingming [1 ]
Liu, Dexi [1 ]
机构
[1] Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA
来源
SCIENTIFIC REPORTS | 2016年 / 6卷
关键词
INDUCED HEPATIC STEATOSIS; PPAR-ALPHA AGONIST; INSULIN-RESISTANCE; ADIPOSE-TISSUE; CALORIE RESTRICTION; OXIDATIVE STRESS; WEIGHT-LOSS; GAMMA; EXPRESSION; OBESITY;
D O I
10.1038/srep26325
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
This study presents the alternating diet as a new strategy in combating obesity and metabolic diseases. Lean or obese mice were fed a high-fat diet (HFD) for five days and switched to a regular diet for one (5 + 1), two (5 + 2), or five (5 + 5) days before switching back to HFD to start the second cycle, for a total of eight weeks (for prevention) or five weeks (for treatment) without limiting animals' access to food. Our results showed that animals with 5 + 2 and 5 + 5 diet alternations significantly inhibited body weight and fat mass gain compared to animals fed an HFD continuously. The dietary switch changed the pattern of daily caloric intake and suppressed HFD-induced adipose macrophage infiltration and chronic inflammation, resulting in improved insulin sensitivity and alleviated fatty liver. Alternating diet inhibited HFD-induced hepatic Ppar gamma-mediated lipid accumulation and activated the expression of Ppar alpha and its target genes. Alternating diet in the 5 + 5 schedule induced weight loss in obese mice and reversed the progression of metabolic disorders, including hepatic steatosis, glucose intolerance, and inflammation. The results provide direct evidence to support that alternating diet represents a new intervention in dealing with the prevalence of diet-induced obesity.
引用
收藏
页数:14
相关论文
共 41 条
  • [1] Anderson JW, 2001, AM J CLIN NUTR, V74, P579
  • [2] Intermittent fasting dissociates beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from calorie intake
    Anson, RM
    Guo, ZH
    de Cabo, R
    Iyun, T
    Rios, M
    Hagepanos, A
    Ingram, DK
    Lane, MA
    Mattson, MP
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (10) : 6216 - 6220
  • [3] Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat
    Braissant, O
    Foufelle, F
    Scotto, C
    Dauca, M
    Wahli, W
    [J]. ENDOCRINOLOGY, 1996, 137 (01) : 354 - 366
  • [4] Time-Restricted Feeding Is a Preventative and Therapeutic Intervention against Diverse Nutritional Challenges
    Chaix, Amandine
    Zarrinpar, Amir
    Phuong Miu
    Panda, Satchidananda
    [J]. CELL METABOLISM, 2014, 20 (06) : 991 - 1005
  • [5] Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans
    Cinti, S
    Mitchell, G
    Barbatelli, G
    Murano, I
    Ceresi, E
    Faloia, E
    Wang, SP
    Fortier, M
    Greenberg, AS
    Obin, MS
    [J]. JOURNAL OF LIPID RESEARCH, 2005, 46 (11) : 2347 - 2355
  • [6] Molecular Mechanisms of Hepatic Steatosis and Insulin Resistance in the AGPAT2-Deficient Mouse Model of Congenital Generalized Lipodystrophy
    Cortes, Victor A.
    Curtis, David E.
    Sukumaran, Suja
    Shao, Xinli
    Parameswara, Vinay
    Rashid, Shirya
    Smith, Amy R.
    Ren, Jimin
    Esser, Victoria
    Hammer, Robert E.
    Agarwal, Anil K.
    Horton, Jay D.
    Garg, Abhimanyu
    [J]. CELL METABOLISM, 2009, 9 (02) : 165 - 176
  • [7] Inflammation: the link between insulin resistance, obesity and diabetes
    Dandona, P
    Aljada, A
    Bandyopadhyay, A
    [J]. TRENDS IN IMMUNOLOGY, 2004, 25 (01) : 4 - 7
  • [8] Hypothalamic control of seasonal changes in food intake and body weight
    Ebling, Francis J. P.
    [J]. FRONTIERS IN NEUROENDOCRINOLOGY, 2015, 37 : 97 - 107
  • [9] The organization, promoter analysis, and expression of the human PPAR gamma gene
    Fajas, L
    Auboeuf, D
    Raspe, E
    Schoonjans, K
    Lefebvre, AM
    Saladin, R
    Najib, J
    Laville, M
    Fruchart, JC
    Deeb, S
    VidalPuig, A
    Flier, J
    Briggs, MR
    Staels, B
    Vidal, H
    Auwerx, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (30) : 18779 - 18789
  • [10] Peroxisome proliferator-activated receptor α ( PPARα) agonist treatment reverses PPARα dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice
    Fischer, M
    You, M
    Matsumoto, M
    Crabb, DW
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (30) : 27997 - 28004